Home › Funds › Aquamarine Financial (Cayman) Ltd › ORMP
Aquamarine Financial (Cayman) Ltd position in ORMP
ORAMED PHARMACEUTICALS INC · Health Care
Aquamarine Financial (Cayman) Ltd reported holding 2,653,567 shares of ORMP (ORAMED PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$12.4M, representing 0.64% of its reported portfolio and ranking #10 among its reported holdings. Aquamarine Financial (Cayman) Ltd has disclosed ORMP holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Aquamarine Financial (Cayman) Ltd's ORMP position evolved
Aquamarine Financial (Cayman) Ltd first disclosed a stake in ORMP in Q3 2025 at 1,973,057 shares (US$5.2M). The position peaked in Q3 2026 at 2,653,567 shares, worth US$12.4M. Across 5 filings, Aquamarine Financial (Cayman) Ltd increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 2,653,567 shares valued at US$12.4M — an increase of 141,392 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 1.97M | $5.21M | New |
| Q4 2025 | 1.97M | $5.62M | Hold |
| Q1 2026 | 2.11M | $7.18M | Add |
| Q2 2026 | 2.51M | $12.08M | Add |
| Q3 2026 | 2.65M | $12.39M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ORMP and 13F data
ORMP (ORAMED PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in ORMP — the largest reported positions include Murchinson Ltd. (US$10.0M), Gem Investment Advisors, LLC (US$9.3M), BML Capital Management, LLC (US$4.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ORMP
- Murchinson Ltd. 2.14M sh · $10.00M · Q3 2026
- Gem Investment Advisors, LLC 2.00M sh · $9.33M · Q3 2026
- BML Capital Management, LLC 884.39K sh · $4.13M · Q3 2026
More on Aquamarine Financial (Cayman) Ltd
FAQ
How long has Aquamarine Financial (Cayman) Ltd held ORMP?
Aquamarine Financial (Cayman) Ltd has disclosed ORMP holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Aquamarine Financial (Cayman) Ltd's current position in ORMP?
As of Q3 2026, Aquamarine Financial (Cayman) Ltd holds 2.65M shares of ORMP (ORAMED PHARMACEUTICALS INC), valued at $12.39M, representing 0.64% of its reported portfolio and ranking #10.
Has Aquamarine Financial (Cayman) Ltd been buying or selling ORMP?
In the latest 13F filing (Q3 2026), Aquamarine Financial (Cayman) Ltd increased its position in ORMP. The position peaked in Q3 2026 at 2.65M shares.
Which other funds hold ORMP?
Other major institutional holders of ORMP include Murchinson Ltd., Gem Investment Advisors, LLC, BML Capital Management, LLC, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.